Scemblix 20 mg
Scemblix 20 mg is a medicine authorised by Swissmedic under authorisation number 68441. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 09 June 2022 and the authorisation is limited until 08 June 2027. ATC code L01EA06 places the medicine in the group Antineoplastic agents.
| Authorisation number | 68441 |
|---|---|
| Name | Scemblix 20 mg |
| Full name | Scemblix 20 mg, Filmtabletten |
| Authorisation holder | Novartis Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01EA06 |
| First authorisation | 09 June 2022 |
| Authorisation validity | 08 June 2027 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Scemblix 20 mg, Filmtabletten | A | 09 June 2022 |
| 2 | Scemblix 40 mg, Filmtabletten | A | 09 June 2022 |
| 3 | Scemblix 100 mg, Filmtabletten | A | 12 May 2025 |
| 4 | Scemblix 20 mg, Filmtabletten | A | 18 June 2024 |
| 5 | Scemblix 40 mg, Filmtabletten | A | 18 June 2024 |
| 6 | Scemblix 100 mg, Filmtabletten | A | 12 May 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 60 | Tablette(n) | L01EA06 | 07.16. | A |
| 2 | 60 | Tablette(n) | L01EA06 | 07.16. | A |
| 5 | 120 | Tablette(n) | L01EA06 | 07.16. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Scemblix 20 mg authorised in Switzerland?
Yes. Scemblix 20 mg is authorised by Swissmedic under authorisation number 68441, data as of 01 September 2026. The authorisation is limited until 08 June 2027.
Which dispensing category does Scemblix 20 mg have?
Scemblix 20 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Scemblix 20 mg?
The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.